Form 4: LifeMD Chairman and CEO Justin Schreiber Sells Shares

Justin Schreiber, Chairman and CEO of LifeMD, Inc., reports the sale of 50,000 shares of common stock at a weighted average price of $7.7808.

Summary

• On April 29, 2025, Justin Schreiber, Chairman and CEO of LifeMD, Inc., sold 50,000 shares of common stock.
• The sale was executed at a weighted average price of $7.7808 per share.
• The prices for the shares sold ranged from $7.500 to $8.150.
• Following the transaction, Schreiber indirectly owns 2,575,721 shares through Schreiber Holdings LLC.
• Schreiber also indirectly owns 13,997 shares each through Child 1 and Child 2.

Sentiment

Score: 4

Explanation: The sentiment is neutral to slightly negative. While insider sales are not inherently negative, they can create uncertainty among investors, especially when the seller is a high-ranking executive like the CEO.

Negatives

• The sale of shares by the CEO could be interpreted negatively by the market.

Risks

• Further sales of shares by insiders could put downward pressure on the stock price.

Industry Context

Insider sales are a common occurrence, but the market often scrutinizes them for signals about a company's prospects. It's important to consider the context of the sale, such as the size of the sale relative to the insider's holdings and the company's overall performance.

Comparison to Industry Standards

• It is difficult to compare this transaction to industry standards without knowing the specific reasons behind the sale and the overall insider trading activity at comparable companies.
• Generally, insider sales are compared to historical insider trading patterns within the company and against peer companies to assess whether the activity is unusual.

Stakeholder Impact

• Shareholders may react to the news of the CEO selling shares, potentially impacting the stock price.

Key Dates

Keywords

LifeMD, Justin Schreiber, share sale, insider trading, LFMD, common stock